The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The purpose of this review is to evaluate the risks associated with long-term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three common indications: gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), and non-steroidal anti-inflammatory drug (NSAID) bleeding prophylaxis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gastroenterology

Title: Gastroenterology

Publisher: Elsevier BV

ISSN (Electronic): 1528-0012

ISSN (Print): 0016-5085

Publication date (Electronic): Mar 2017

Volume: 152

Issue: 4

Affiliations

[1 ] Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York. Electronic address: def2004@cumc.columbia.edu.

[2 ] South Denver Gastroenterology, P.C., Littleton, Colorado.

[3 ] Divison of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Article

Publisher Item ID: S0016-5085(17)30091-4

DOI: 10.1053/j.gastro.2017.01.031

PubMed ID: 28257716

SO-VID: 945bf877-0daa-4380-a9dd-dc907995d602

History

Data availability:

Comments

Comment on this article

scite_

Cited by 239

See all cited by

- Version 1